Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis

被引:6
|
作者
Nishikawa, Tatsuya [1 ]
Kunimasa, Kei [2 ]
Ohta-Ogo, Keiko [3 ]
Ikeda, Yoshihiko [3 ]
Yasui, Taku [1 ]
Shioyama, Wataru [1 ]
Oka, Toru [1 ]
Honma, Keiichiro [4 ]
Hatakeyama, Kinta [3 ]
Kumagai, Toru [2 ]
Fujita, Masashi [1 ]
机构
[1] Osaka Int Canc Inst, Dept Oncocardiol, Osaka, Japan
[2] Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan
[4] Osaka Int Canc Inst, Dept Pathol, Osaka, Japan
关键词
case report; cardio-oncology; sick sinus syndrome; pembrolizumab; immune-related adverse event; myocarditis; EVENTS;
D O I
10.2169/internalmedicine.8575-21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune checkpoint inhibitor (ICI)-induced myocarditis is a potentially life-threatening adverse event. We herein report a rare case of sick sinus syndrome (SSS) co-occurring with ICI-associated myocarditis. A 71 -year-old woman with lung cancer undergoing pembrolizumab monotherapy was admitted owing to a fever, worsening kidney function, and sinus bradycardia. She was diagnosed with multi-organ immune-related ad-verse events, including myocarditis. Pulse steroid therapy was initiated immediately under the support of a temporary pacemaker, which resulted in the resolution of SSS in a few days. Biopsy specimens of the endo-myocardium showed active myocarditis. Thus, we should be aware that SSS can co-occur with ICI-induced myocarditis.
引用
收藏
页码:2161 / 2165
页数:5
相关论文
共 50 条
  • [1] Immune Checkpoint Inhibitor-Associated Myocarditis: A Rare Presentation With Atrioventricular Block and Sinus Node Dysfunction
    Cardoso, Isabel
    Ferreira, Vera Vaz
    Guerreiro, Ines
    Alfarroba, Sara
    Winckler, Patricia
    Mano, Tania
    Morais, Luis
    Thomas, Boban
    Ferreira, Rui Cruz
    CJC OPEN, 2023, 5 (11) : 829 - 832
  • [2] Immune Checkpoint Inhibitor-Associated Myocarditis
    Ganatra, Sarju
    Neilan, Tomas G.
    ONCOLOGIST, 2018, 23 (08): : 879 - 886
  • [3] Treatment of Immune Checkpoint Inhibitor-associated Myocarditis
    Heemelaar, Julius C.
    Louisa, Maria
    Neilan, Tomas G.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (05) : 384 - 391
  • [4] Reporting of immune checkpoint inhibitor-associated myocarditis
    Al-Kindi, Sadeer G.
    Oliveira, Guilherme H.
    LANCET, 2018, 392 (10145): : 382 - 383
  • [5] Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis
    Tanabe, Junya
    Watanabe, Nobuhide
    Endo, Akihiro
    Nagami, Taichi
    Inagaki, Satoshi
    Tanabe, Kazuaki
    INTERNAL MEDICINE, 2021, 60 (04) : 569 - 573
  • [6] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED FULMINANT MYOCARDITIS
    Yan, Crystal L.
    Rodriguez, Beatriz P. Rivera
    Lopez, Juan
    Martinez, Moises Vasquez
    Andrade-Bucknor, Sharon N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3457 - 3457
  • [7] Electrocardiographic Features of Immune Checkpoint Inhibitor-Associated Myocarditis
    Song, Wenhua
    Zheng, Yi
    Dong, Mei
    Zhong, Lin
    Bazoukis, George
    Perone, Francesco
    Li, Guangping
    Ng, Chi Fai
    Baranchuk, Adrian
    Tse, Gary
    Liu, Tong
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (02)
  • [8] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS: A CASE REPORT
    Saeed, Mariam
    Khan, Zinobia
    Bachan, Moses
    Raju, Bindu
    Khan, Muneer
    CRITICAL CARE MEDICINE, 2020, 48
  • [9] Immune Checkpoint Inhibitor-Associated Myocarditis: A Literature Review
    Gul, Rohail
    Shehryar, Muhammad
    Mahboob, Anber
    Kareem, Hira K.
    Inayat, Arslan
    Safi, Danish
    Kamran, Amir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [10] Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis
    Salem, Joe-Elie
    Allenbach, Yves
    Vozy, Aurore
    Brechot, Nicolas
    Johnson, Douglas B.
    Moslehi, Javid J.
    Kerneis, Mathieu
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24): : 2377 - 2379